AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2011
Oct 24, 2011
35134_dirs_2011-10-24_d035e973-34c2-4a29-9c90-ca72e0ec04d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (AMHND)
CIK: 0000025743
Period of Report: 2011-10-21
Reporting Person: Cartwright Daniel A (CFO, VP Finance, Treasurer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-21 | Non-qualified stock option | $0.38 | A | 300000 | Acquired | 2021-10-21 | Common Stock (300000) | Direct |
| 2011-10-21 | Warrant | $0.038 | A | 600000 | Acquired | 2021-10-21 | Common Stock (600000) | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16